| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药贸易(元) | 72,278,266.35 | 117,525,105.95 | 62,911,491.76 | 111,085,449.35 | 61,995,370.83 |
| 医药制造(元) | 1,283,671,740.95 | 2,482,634,053.18 | 1,414,979,161.74 | 2,554,343,125.56 | 1,255,420,002.53 |
| 营业成本(元) | |||||
| 医药贸易(元) | 64,347,278.47 | 105,981,218.13 | 57,164,910.72 | 104,567,051.03 | 58,830,702.25 |
| 医药制造(元) | 518,641,446.37 | 969,187,476.59 | 508,385,572.67 | 829,532,560.26 | 388,133,222.36 |
| 毛利(元) | |||||
| 医药贸易(元) | 7,930,987.88 | 11,543,887.82 | 5,746,581.04 | 6,518,398.32 | 3,164,668.58 |
| 医药制造(元) | 765,030,294.58 | 1,513,446,576.59 | 906,593,589.07 | 1,724,810,565.30 | 867,286,780.17 |
| 毛利率(%) | |||||
| 医药贸易(%) | 10.97 | 9.82 | 9.13 | 5.87 | 5.10 |
| 医药制造(%) | 59.60 | 60.96 | 64.07 | 67.52 | 69.08 |
| 收入构成(%) | |||||
| 医药贸易(%) | 5.33 | 4.52 | 4.26 | 4.17 | 4.71 |
| 医药制造(%) | 94.67 | 95.48 | 95.74 | 95.83 | 95.29 |
| 毛利构成(%) | |||||
| 医药贸易(%) | 1.03 | 0.76 | 0.63 | 0.38 | 0.36 |
| 医药制造(%) | 98.97 | 99.24 | 99.37 | 99.62 | 99.64 |